WATERS CORP
corporate_fare Company Profile
WATERS CORP (NYSE:WAT) is a publicly traded company in the Life Sciences sector. Wiseek monitors WAT SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Waters Launches Xevo TQ Absolute XR IVD with 5x Sensitivity Boost for Clinical Labs
- Waters Launches Industry-First Bioseparation Columns, Delivering Up to 3x Faster GLP-1 Characterization
- Waters Secures FDA Clearance for BD BACTEC FXI System, Enhancing Sepsis Diagnostics
- Waters Unveils Xevo MRT P10 MS with 20x Sensitivity Boost, Accelerating Multiomics Research
- Waters Corp Reports Q1 GAAP Net Loss of $72M, EPS $(0.87) Due to Acquisition Costs
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for WAT, detected from its recent SEC filings · based on capital-structure filings through 2026-03-17.
Finalizes $3.5 Billion Senior Notes Offering · Supports Major Acquisition Financing
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →